Intervention Treatment
ALERTS (AngelMed Implantable Monitor for Early Recognition and Treatment of ST Elevation MI)
- Principal Investigator: Ian Gilchrist, MD
- Nurse Coordinator: Dena Jefferson, RN 717-531-5967
PFO Access: Documented PFO who have experienced at least two cryptogentic strokes.
- Principal Investigator: Mark Kozak, MD
- Nurse Coordinator: Dena Jefferson, RN 717-531-5967
- Principal Investigator: Mark Kozak, MD
- Study Coordinator: LaDora Field, RCT 531-1468
The Treatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study is a prospective, observational longitudinal study to evaluate the real world effectiveness and use of prasugrel and other ADP receptor inhibitor therapies among myocardial infarction (MI) patients treated with percutaneous coronary intervention (PCI) during the index hospitalization. Patient management and treatment decisions are at the discretion of the care team per routine clinical practice.
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
- Principal Investigator: Mark Kozak, MD
- Study Coordinator: Dena Jefferson, RN 531-5967
The purpose of this trial is to test the hypothesis that canakinumab treatment of patients with MI at least one month prior to study entry and elevated hsCRP will prevent recurrent cardiovascular events